Delivery Order SPE2D119D7009-SPE2D526F3353
- Not listed
- Hamilton Medical, Inc. has been awarded a $1,633.05 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain for HAMILTON-C3/C2/C1/T1/MR1 oxygen cells, with a completion date of August 27, 2025. The contract, issued on June 2, 2025, does not utilize any small business or socioeconomic set-aside designations. Performance will be conducted at Hamilton Medical's facility in Reno, Nevada. Hamilton Medical, Inc. is a foreign-owned medical device manufacturer specializing in...
- Hamilton Medical, Inc. has been awarded a fixed-price delivery order valued at $1,553.36 for the supply of HAMILTON-C3/C2/C1/T1/MR1 oxygen cells to the Defense Logistics Agency's Medical Supply Chain division. The contract, awarded on July 23, 2025, with an ultimate completion date of October 17, 2025, represents a continuation of Hamilton Medical's ongoing supply relationship with the federal government. No small business or socioeconomic set-aside designation was utilized for this award....
- Hamilton Medical, Inc. was awarded a fixed-price delivery order valued at $3,266.10 on July 25, 2025, for HAMILTON-C3/C2/C1/T1/MR1 oxygen cells with an ultimate completion date of October 21, 2025. The contract, which does not utilize a set-aside designation, supports the Defense Logistics Agency's Medical Supply Chain operations and will be performed in Reno, Nevada. Hamilton Medical, a foreign-owned medical device manufacturer, specializes in advanced respiratory medical equipment and...
- Hamilton Medical, Inc. has been awarded a $13,712.64 fixed-price delivery order with economic price adjustment for HAMILTON-C3/C2/C1/T1/MR1 oxygen cells by the Department of Defense's Medical Supply Chain division. The contract, awarded on April 25, 2025, with an ultimate completion date of July 23, 2025, will be performed in Reno, Nevada. This delivery order was issued without a set-aside designation, allowing Hamilton Medical to compete as a prime contractor on an unrestricted basis....
- Hamilton Medical, Inc., a foreign-owned medical device manufacturer headquartered in Reno, Nevada, was awarded a fixed-price delivery order valued at $1,088.70 by the Medical Supply Chain (a Defense agency component) on October 22, 2025, for the delivery of Oxygen Cell 1S units. The contract carries no set-aside designation and requires completion by January 21, 2026, with performance taking place in Reno, Nevada. This delivery order represents a continuation of Hamilton Medical's established...
- Hamilton Medical, Inc., a foreign-owned medical device manufacturer based in Reno, Nevada, was awarded a $1,088.70 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain function on September 17, 2025, for the supply of oxygen cells. The contract, classified as a delivery order with economic price adjustment provisions, carries an ultimate completion date of December 12, 2025, with performance occurring at the company's Reno, Nevada facility. No set-aside designation...
- Hamilton Medical, Inc. was awarded a $1,088.70 fixed-price delivery order with economic price adjustment on December 17, 2025, for the delivery of oxygen cells (1S model). The contract is not set-aside and has an ultimate completion date of March 17, 2026. Work will be performed in Reno, Nevada, where Hamilton Medical maintains its headquarters. The funding agency is the Medical Supply Chain, a defense-focused federal entity responsible for procuring medical equipment and supplies. This delivery...
- The U.S. government's Defense Logistics Agency Troop Support Medical has awarded a $2,018.02 fixed-price delivery order to Hamilton Medical, Inc., a foreign-owned for-profit medical device manufacturer. The award is for the delivery of HAMILTON-C3/C2/C1/T1/MR1 oxygen cells, which are components used in the company's line of intelligent ventilation solutions. This award is part of Hamilton Medical's Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract under the General Services...
- This federal contract award is for the supply of HAMILTON-C3/C2/C1/T1/MR1 oxygen cells to the Medical Supply Chain of the Defense Logistics Agency (DLA). The $1,306.44 fixed-price with economic price adjustment contract was awarded to Hamilton Medical, Inc., a foreign-owned, for-profit medical device manufacturer based in Reno, Nevada. Hamilton Medical specializes in advanced medical ventilation technologies and equipment, and has an Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract with...
- The federal contract award is for the supply of HAMILTON-C3/C2/C1/T1/MR1 oxygen cells to the Defense Logistics Agency (DLA), which is the primary logistics combat support agency for the United States Department of Defense. The contract, which is a fixed-price delivery order with economic price adjustment, has a ceiling value of $2,177.40 and an ultimate completion date of August 28, 2025. The prime contractor is Hamilton Medical, Inc., a foreign-owned, for-profit medical device manufacturer...
- SPE2D119D7009Indefinite Delivery Contract
- SPE2D119D7009-SPE2D526F3353Delivery Order
Hamilton Medical, Inc. was awarded a fixed-price delivery order valued at $1,633.05 on December 17, 2025, for the supply of HAMILTON-C3/C2/C1/T1/MR1 oxygen cells. The contract, which carries no set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain office and will be performed in Reno, Nevada, with an ultimate completion date of March 17, 2026. Hamilton Medical, a foreign-owned medical device manufacturer headquartered in Reno, specializes in advanced medical ventilation technologies and serves as a prime contractor across multiple federal procurement channels, including a substantial Indefinite-Delivery/Indefinite-Quantity contract valued at $22.9 million under the General Services Administration's Medical Equipment and Supplies Federal Supply Schedule. This delivery order represents a continuation of Hamilton Medical's established role as a critical supplier of respiratory medical equipment and accessories to federal healthcare and defense entities. The company's oxygen cells are essential components utilized within Hamilton Medical's ventilator systems, which support patient care across Department of Defense facilities, the Department of Veterans Affairs, and the Department of Health and Human Services. The fixed-price structure with economic price adjustment provides cost stability while allowing for adjustments based on specified economic factors, ensuring predictable procurement outcomes for federal medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/16/25 |